妇科肿瘤及泌尿生殖系统肿瘤，恶性黑色素瘤及软组织肉瘤等常见肿瘤诊治

专业方向： 从事常见肿瘤的诊疗工作，近年主要从事妇科、泌尿生殖肿瘤、恶性黑色素瘤及肉瘤方面的诊治等 医生简介： 蒋葵，女，教授，硕士生导师，妇瘤及泌尿生殖肿瘤科主任。曾于中科院肿瘤医院肿瘤内科、美国Mayo Clinical 生化及分子生物实验室研修。主持并参与多项国家级及省市级课题，发表文章20余篇, 其中以通讯作者或第一作者发表SCI文章6篇。现任辽宁省医学会肿瘤分会委员，中国老年学和老年医学学会肿瘤康复分会委员，中国医疗保健国际交流促进会肿瘤姑息治疗与人文关怀分会委员，大连市医学会肿瘤专科分会副主任委员等多项任职。收起 研究方向： 卵巢癌及肾癌、前列腺癌的内科治疗及预后影响因素。 在研项目： 二甲双胍通过激活AMPK通路增强PARP抑制剂治疗同源重组修复正常型卵巢癌的有效性及其分子机制研究--国家自然基金项目 (81874111)第一完成人 代表文章： 1.Jumonji AT-rich interactive domain 1B over expression is associated with the development and progression of glioma.LIPING FANG, JIUHAN ZHAO, DAN WANG, LIYU ZHU, JIAN WANG, KUI JIANG. Int J Mol Med. 2016 July; 38(1): 172–182. IF: 2.341 2.Expression of Adiponectin Receptor-1 and Prognosis of Epithelial Ovarian Cancer Patients.Li X1, Yu Z1, Fang L1, Liu F2, Jiang K1.Med Sci Monit. 2017 Mar 30;23:1514-1521.IF: 1.4 3.Knockdown of long noncoding RNA CCAT1 inhibits cell growth, invasion and peritoneal metastasis via downregulation of Bmi-1 in gastric cancer.Li N, Jiang K, Fang LP, Yao LL, Yu Z. Neoplasm. 2018 Cep 19;65(5): 736-744.IF: 1.696 4.Phosphorylated retinoblastoma is a biomarker of overall disease control and better progression-free survival of recurrent epithelial ovarian cancer patients treated with second-line topoisomerase inhibitor CPT-11 chemotherapy.Kui Jiang, Guangyan Gao, Lulu Yao.Transl Cancer Res 2018;7(6):1682-1693. IF:1.2 5.Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits.Jiaojiao Hao, Wenhua Fan, Yizhuo Li, Ranran Tang, Chunfang Tian, Qian Yang, Tianhua Zhu, Chaoliang Diao, Sheng Hu, Manyu Chen, Ping Guo, Qian Long, Changlin Zhang, Ge Qin, Wendan Yu, Miao Chen, Liren Li, Lijun Qin, Jingshu Wang, Xiuping Zhang, Yandong Ren, Penghui Zhou, Lijuan Zou, Kui Jiang, Wei Guo, Wuguo Deng. J Exp Clin Cancer Res. 2019; 38: 48.IF:5.646.